Diabetic retinal disease is envisioned to become the plague of the coming decades with a
steep increase of worldwide diabetes incidence followed by a substantial rise in retinal …

Purpose To review the current therapeutic options for the management of diabetic
retinopathy (DR) and diabetic macular edema (DME) and examine the evidence for …

Background: Diabetic retinopathy is a leading cause of visual impairment in working-age
adults worldwide. Duration of diabetes is a major risk factor associated with the development …

Abstract Purpose of Review This review highlights indications and evidence on laser
therapy in the management of diabetic retinopathy and diabetic macular edema. Particular …

Diabetic macular edema (DME), a serious eye complication caused primarily by
hyperglycemia, is one of the major causes of blindness. DME, which is characterized by …

Diabetes mellitus is a world-wide epidemic and diabetic retinopathy, a devastating, vision-
threatening condition, is one of the most common diabetes-specific complications. Diabetic …

Glaucoma, a progressive optic neuropathy, is the leading cause of irreversible blindness
worldwide. Glaucoma patients are usually initially managed with medications and laser …

Purpose To provide evidence-based recommendations for diabetic macular edema (DME)
management based on updated information from publications on DME treatment modalities …

Purpose: To determine the safety of transfoveal subthreshold diode micropulse laser for
fovea-involving diabetic macular edema. Methods: The records of all patients treated with …

Medicinal lasers are a standard source of light to produce retinal tissue photocoagulation to
treat retinovascular disease. The Diabetic Retinopathy Study and the Early Treatment …